Why phenylephrine hydrochloride + chloropehenramine maleate syrup is banned in india
Reading File
Searching the Web
India phenylephrine hydrochloride chlorpheniramine maleate syrup ban under 4 years official notification CDSCO 2024
Finding Sources
Searching PubMed
phenylephrine AND chlorpheniramine
Reading Web Page
https://www.pib.gov.in/PressReleasePage.aspx?PRID=2302237
Finding Sources
It is not a complete ban for everyone.
In India, fixed-dose syrups containing phenylephrine hydrochloride + chlorpheniramine maleate are restricted because of safety concerns in children below 4 years. The government requires the warning:
“Fixed Dose Combination shall not be used in children below four years of age.”
The restriction followed recommendations from an Expert Committee and the Drugs Technical Advisory Board. The stated basis is that these combinations can pose risks in young children and safer alternatives are available. See the Government announcement and the CDSCO notification listing.
Why young children are at higher risk
- Chlorpheniramine is a sedating antihistamine. It can cause excessive sleepiness, agitation, dry mouth, and, in overdose or sensitive children, breathing-related and nervous-system problems.
- Phenylephrine is a decongestant that constricts blood vessels. It may cause increased heart rate or blood pressure, palpitations, restlessness, and irritability.
- In small children, cold-cough syrups have limited proven benefit for ordinary viral colds, while dosing mistakes and duplicate ingredients from multiple syrups are common.
So, the practical interpretation is:
- Below 4 years: Do not use this combination.
- Age 4 years and above/adults: Not automatically banned, but use only if prescribed or advised by a clinician, and avoid combining it with other cold medicines containing antihistamines or decongestants.
For a child with a common cold, saline nasal drops/spray, fluids, and age-appropriate fever treatment if needed are generally safer first measures. Seek medical care urgently for breathing difficulty, blue lips, marked drowsiness, poor feeding, dehydration, or fever in a very young infant.
This is a shared conversation. Sign in to Orris to start your own chat.